Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Clinical Psychiatry|August 25, 2015
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressantsMichael E Thase, James M Youakim, Aleksandar Skuban, et al.
Med (New York, N.Y.)|June 25, 2024
Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Med (New York, N.Y.)|July 18, 2024
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Nature Medicine|June 8, 2023
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 studyJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Pediatric Neurology|January 17, 2024
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett SyndromeJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Frontiers in Pharmacology|February 6, 2024
Development of trofinetide for the treatment of Rett syndrome: from bench to bedsideMelissa Kennedy, Larry Glass, Daniel G Glaze, et al.
The New England Journal of Medicine|July 21, 2021
Trial of Pimavanserin in Dementia-Related PsychosisPierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.
Journal of Comparative Effectiveness Research|November 16, 2023
Gastrointestinal manifestations in pediatric and adult patients with Rett syndrome: an analysis of US claims and physician survey dataDamian M May, Jeffrey Neul, Jesús Eric Piña-Garza, et al.
Med (New York, N.Y.)|March 5, 2025
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndromeAlan K Percy, Robin Ryther, Eric D Marsh, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker ResearchCorinne E Fischer, Zahinoor Ismail, James M Youakim, et al.
Pageof 3